| Prion diseases (hsa05020) |
2.820E-09 |
| Signaling pathways regulating pluripotency of stem cells (hsa04550) |
2.820E-09 |
| Proteoglycans in cancer (hsa05205) |
6.454E-09 |
| Adherens junction (hsa04520) |
2.600E-07 |
| ECM-receptor interaction (hsa04512) |
4.887E-07 |
| Hippo signaling pathway (hsa04390) |
5.721E-07 |
| TGF-beta signaling pathway (hsa04350) |
2.408E-06 |
| Axon guidance (hsa04360) |
1.494E-05 |
| Rap1 signaling pathway (hsa04015) |
2.388E-05 |
| Pathways in cancer (hsa05200) |
4.904E-05 |
| Prostate cancer (hsa05215) |
9.959E-05 |
| Transcriptional misregulation in cancer(hsa05202) |
1.580E-04 |
| Endocytosis (hsa04144) |
2.308E-04 |
| Oocyte meiosis (hsa04114) |
2.410E-04 |
| Regulation of actin cytoskeleton (hsa04810) |
3.968E-04 |
| Focal adhesion (hsa04510) |
5.100E-04 |
| Thyroid hormone signaling pathway (hsa04919) |
6.869E-04 |
| Bacterial invasion of epithelial cells (hsa05100) |
9.954E-04 |
| Glutamatergic synapse (hsa04724) |
9.954E-04 |
| PI3K-Akt signaling pathway (hsa04151) |
1.011E-03 |
| Ras signaling pathway (hsa04014) |
1.515E-03 |
| Melanoma (hsa05218) |
1.708E-03 |
| Glioma (hsa05214) |
1.872E-03 |
| GABAergic synapse (hsa04727) |
1.959E-03 |
| Arrhythmogenic right ventricular cardiomyopathy (ARVC) (hsa05412) |
2.330E-03 |
| Gap junction (hsa04540) |
4.817E-03 |
| FoxO signaling pathway (hsa04068) |
5.137E-03 |
| Thyroid cancer (hsa05216) |
5.369E-03 |
| Inositol phosphate metabolism (hsa00562) |
7.351E-03 |
| Acute myeloid leukemia (hsa05221) |
8.747E-03 |
| Mucin type O-Glycan biosynthesis (hsa00512) |
9.315E-03 |
| Wnt signaling pathway (hsa04310) |
9.315E-03 |
| Colorectal cancer (hsa05210) |
1.070E-02 |
| Long-term potentiation (hsa04720) |
1.070E-02 |
| Adrenergic signaling in cardiomyocytes(hsa04261) |
1.285E-02 |
| Oxytocin signaling pathway (hsa04921) |
1.620E-02 |
| Amphetamine addiction (hsa05031) |
1.954E-02 |
| Shigellosis (hsa05131) |
2.067E-02 |
| Long-term depression (hsa04730) |
2.067E-02 |
| Dorso-ventral axis formation (hsa04320) |
2.232E-02 |
| Phosphatidylinositol signaling system (hsa04070) |
2.575E-02 |
| Ubiquitin mediated proteolysis (hsa04120) |
2.832E-02 |
| mRNA surveillance pathway (hsa03015) |
3.431E-02 |
| ErbB signaling pathway (hsa04012) |
3.431E-02 |
| Mineral absorption (hsa04978) |
4.049E-02 |
| Choline metabolism in cancer (hsa05231) |
4.363E-02 |
| Endocrine and other factor-regulated calcium reabsorption (hsa04961) |
4.613E-02 |
| Chronic myeloid leukemia (hsa05220) |
4.944E-02 |
